Synapse - Works

Results (5608)

Frequency and function of ERBB3 mutations in bladder cancer

Meeting Abstract

Hanrahan, A. J.; Sfakianos, J. P.; Ramirez, R.; Kim, P. H.; Iyer, G.; Al-Ahmadie, H. A.; Scott, S. N.; Bajorin, D. F.; Bochner, B. H.; Coleman, J. A.; more...
Cancer Research (2014)

Fulltext@MSK | Save

The landscape of actionable genomic lesions in small cell bladder cancer

Meeting Abstract

Chang, M. T.; Asthana, S.; Iyer, G.; Desai, N.; Al-Ahmadie, H.; Chapman, J.; Bochner, B. H.; Rosenberg, J. E.; Bajorin, D. F.; Solit, D. B.; more...
Cancer Research (2014)

Fulltext@MSK | Save

Loss of PTEN leads to clinical resistance to the PI3K alpha inhibitor BYL719 and provides evidence of convergent evolution under selective therapeutic pressure

Meeting Abstract

Castel, P.; Juric, D.; Won, H.; Ainscough, B.; Ellis, H.; Ebbesen, S.; Griffith, M.; Griffith, O.; Iyer, G.; Sgroi, D.; more...
Cancer Research (2014)

Fulltext@MSK | Save

Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients

Meeting Abstract

Carrasquillo, J. A.; Danila, D. C.; Beylergil, V.; O'Donoghue, J. A.; Cheal, S. M.; Ruan, S. T.; Pandit-Taskar, N.; Fox, J. J.; Fleming, S. E.; Zanzonico, P. B.; more...
Cancer Research (2014)

Fulltext@MSK | Save

Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)

Journal Article

Armstrong, A. J.; Kaboteh, R.; Carducci, M. A.; Damber, J. E.; Stadler, W. M.; Hansen, M.; Edenbrandt, L.; Forsberg, G.; Nordle, T.; Pili, R.; more...
Urologic Oncology: Seminars and Original Investigations (2014)

Fulltext@MSK | Save

Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma

Journal Article

Motzer, R. J.; Hutson, T. E.; Hudes, G. R.; Figlin, R. A.; Martini, J. F.; English, P. A.; Huang, X.; Valota, O.; Williams, J. A.
Cancer Chemotherapy and Pharmacology (2014)

Fulltext@MSK | Save

Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects

Meeting Abstract

Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
Blood (2014)

Fulltext@MSK | Save

Molecular imaging with 89Zr anti-PSMA targeted PET/CT: Percutaneous biopsies of prostate cancer metastasis can be accurately performed without reinjection

Meeting Abstract

Cornelis, F.; Durack, J. C.; Pandit-Taskar, N.; Morris, M.; Solomon, S. B.
European Journal of Nuclear Medicine and Molecular Imaging (2014)

Fulltext@MSK | Save

CTLA-4 antibodies: New directions, new combinations

Journal Article

Funt, S. A.; Page, D. B.; Wolchok, J. D.; Postow, M. A.
Oncology (Norwalk) (2014)

Fulltext@MSK | Save

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

Journal Article

Milowsky, M. I.; Dittrich, C.; Durán, I.; Jagdev, S.; Millard, F. E.; Sweeney, C. J.; Bajorin, D.; Cerbone, L.; Quinn, D. I.; Stadler, W. M.; more...
European Journal of Cancer (2014)

Fulltext@MSK | Save